OS Therapies cautions readers that forward-looking statements are based on management’s expectations and assumptions as of the date of this news release and are subject to certain risks and ...

OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic ...

(RTTNews) - OS Therapies (OSTX) has submitted a request for Regenerative Medicine Advanced Therapy Designation to FDA for OST-HER2 in the prevention of metastases in recurrent, fully-resected ...

OS Therapies Inc., a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced it has submitted a request for Regenerative Medicine Advanced Therapy ...

Instead of making a straightforward request or voicing a direct want, someone who is dry begging hints at a need or makes a vague complaint, Cetnar added. So, instead of stating, “I wish we spent more ...

NEW YORK, June 06, 2025--OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today ...

OS Therapies Submits Request for Regenerative Medicine ... Designation to U.S. FDA for OST-HER2 in the Prevention ... and their inclusion on this site does not imply any form of ...

ITR Filing 2025: The income tax filing season 2025 has started, with the Excel Utilities for ITR-1 and ITR-4 already available for download on the e-filing portal. So far, a total of 1,23,075 ITRs ...

CAMBRIDGE, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that ...